These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant. Ahmed MH; Khalil AA Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168 [TBL] [Abstract][Full Text] [Related]
3. Treatment with ezetimibe in kidney transplant recipients with uncontrolled dyslipidemia. López V; Gutiérrez C; Gutiérrez E; Sola E; Cabello M; Burgos D; González Molina M Transplant Proc; 2008 Nov; 40(9):2925-6. PubMed ID: 19010149 [TBL] [Abstract][Full Text] [Related]
4. Statins and solid organ transplantation. Gazi IF; Liberopoulos EN; Athyros VG; Elisaf M; Mikhailidis DP Curr Pharm Des; 2006; 12(36):4771-83. PubMed ID: 17168777 [TBL] [Abstract][Full Text] [Related]
9. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. Taber DJ; Pilch NA; Meadows HB; McGillicuddy JW; Bratton CF; Chavin KD; Baliga PK; Egede LE J Cardiovasc Pharmacol Ther; 2013 May; 18(3):243-50. PubMed ID: 23258931 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease in live related renal transplantation. Kaul A; Sharm RK; Gupta A; Sinha N; Singh U J Assoc Physicians India; 2011 Nov; 59():715-8. PubMed ID: 22616338 [TBL] [Abstract][Full Text] [Related]
11. Renal transplantation in high cardiovascular risk patients. Bittar J; Arenas P; Chiurchiu C; de la Fuente J; de Arteaga J; Douthat W; Massari PU Transplant Rev (Orlando); 2009 Oct; 23(4):224-34. PubMed ID: 19520563 [TBL] [Abstract][Full Text] [Related]
12. Managing Cardiovascular Risk in the Post Solid Organ Transplant Recipient. Munagala MR; Phancao A Med Clin North Am; 2016 May; 100(3):519-33. PubMed ID: 27095643 [TBL] [Abstract][Full Text] [Related]
13. Ezetimibe in heart transplantation: initial experience. Moro J; Almenar L; Martínez-Dolz L; Izquierdo M; Agüero J; Sánchez-Lazaro I; Ortiz V; Salvador A Transplant Proc; 2007 Sep; 39(7):2389-92. PubMed ID: 17889199 [TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725 [TBL] [Abstract][Full Text] [Related]
15. Initial kidney graft resistance index and the long-term cardiovascular mortality in transplanted patients: a paired grafts analysis. Kolonko A; Chudek J; Więcek A Nephrol Dial Transplant; 2015 Jul; 30(7):1218-24. PubMed ID: 25839739 [TBL] [Abstract][Full Text] [Related]
16. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Gotto AM; Farmer JA Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799 [TBL] [Abstract][Full Text] [Related]
17. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death. Aalten J; Hoogeveen EK; Roodnat JI; Weimar W; Borm GF; de Fijter JW; Hoitsma AJ Transpl Int; 2008 Oct; 21(10):985-91. PubMed ID: 18564985 [TBL] [Abstract][Full Text] [Related]
18. [Ezetimibe (Ezetrol) in patients with diabetes]. Scheen AJ; Radermecker RP Rev Med Liege; 2009 Dec; 64(12):606-11. PubMed ID: 20143743 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular complications after renal transplantation and their prevention. Ojo AO Transplantation; 2006 Sep; 82(5):603-11. PubMed ID: 16969281 [TBL] [Abstract][Full Text] [Related]
20. Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population. Puthenparumpil JJ; Keough-Ryan T; Kiberd M; Lawen J; Kiberd BA Transplant Proc; 2005 Mar; 37(2):1033-5. PubMed ID: 15848614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]